{"context_annotations": [{"domain": {"id": "47", "name": "Brand", "description": "Brands and Companies"}, "entity": {"id": "1100410844427350016", "name": "CNBC", "description": "CNBC"}}, {"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "author_id": "1158298350380150784", "entities": {"urls": [{"start": 116, "end": 139, "url": "https://t.co/qT95XMweDU", "expanded_url": "https://www.businesswire.com/news/home/20200518005348/en/Moderna-Announces-Positive-Interim-Phase-1-Data", "display_url": "businesswire.com/news/home/2020\u2026"}], "mentions": [{"start": 0, "end": 8, "username": "CNBCnow", "id": "26574283"}]}, "referenced_tweets": [{"type": "replied_to", "id": "1262346863761657857"}], "id": "1262367495127592961", "lang": "en", "in_reply_to_user_id": "26574283", "text": "@CNBCnow Moderna announces positive interim Phase 1 data for its mRNA vaccine (mRNA-1273) against novel coronavirus https://t.co/qT95XMweDU", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "conversation_id": "1262346863761657857", "created_at": "2020-05-18T13:00:39.000Z", "source": "Twitter for iPhone", "reply_settings": "everyone", "possibly_sensitive": false}